Cargando…

The effect of Timolol 0.5% on the correction of myopic regression after LASIK

BACKGROUD: Postlaser in situ keratomileusis (post-LASIK) refractive regression is defined as the gradual, partial, or total loss of initial correction that limits the predictability, efficiency, and long-term stability of LASIK. Our study assesses the effect of Timolol 0.5% on the correction of myop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Hong, Gao, Caifeng, Li, Yaxin, Feng, Xue, Wang, Miao, Zhang, Yu, Chen, Yueguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413280/ https://www.ncbi.nlm.nih.gov/pubmed/28445315 http://dx.doi.org/10.1097/MD.0000000000006782

Ejemplares similares

Effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: Clinical and topographical outcomes
por: Singh, Aastha, et al.
Publicado: (2020)

Single-Step Transepithelial PRK vs Alcohol-Assisted PRK in Myopia and Compound Myopic Astigmatism Correction
por: Kaluzny, Bartlomiej J., et al.
Publicado: (2016)

Longitudinal Evaluation of Cornea With Swept-Source Optical Coherence Tomography and Scheimpflug Imaging Before and After Lasik
por: Chan, Tommy C.Y., et al.
Publicado: (2015)

Comparison of Corneal Optical Quality After SMILE, Wavefront-Optimized LASIK and Topography-Guided LASIK for Myopia and Myopic Astigmatism
por: Zhang, Yu, et al.
Publicado: (2022)

Comparison of safety and efficiency of corneal topography-guided photorefractive keratectomy and combined with crosslinking in myopic correction: An 18-month follow-up
por: Li, Li, et al.
Publicado: (2021)

Self-limited corneal ectasia in a post-LASIK eye after cataract surgery: A case report
por: Chang, Hao-Yun, et al.
Publicado: (2023)

Retinal Nerve Fiber Layer Thickness in Myopic, Emmetropic, and Hyperopic Children
por: Lee, Jacky W.Y., et al.
Publicado: (2015)

A randomized controlled trial involving college student: Comparing 0.15% hyaluronic acid with 0.05% cyclosporine A and 3% diquafosol sodium in the Treatment of Dry Eye
por: Xu, Wenhao, et al.
Publicado: (2023)

Changes in Anterior Chamber After Myopic and Hyperopic FS-LASIK
por: Wang, Zizhen, et al.
Publicado: (2022)

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
por: Schnober, Dietmar, et al.
Publicado: (2015)

Interface Fluid Syndrome Induced by Uncontrolled Intraocular Pressure Without Triggering Factors After LASIK in a Glaucoma Patient: A Case Report
por: Shoji, Nobuyuki, et al.
Publicado: (2015)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue, Kenji, et al.
Publicado: (2015)

Quantitative analysis with volume rendering of pathological myopic eyes by high-resolution three-dimensional magnetic resonance imaging
por: Zhou, Jinqiong, et al.
Publicado: (2020)

Efficacy of lutein supplements on macular pigment optical density in highly myopic individuals: A randomized controlled trial
por: Yoshida, Takeshi, et al.
Publicado: (2023)

Visual outcomes after balanced salt solution infiltration during lenticule separation in small-incision lenticule extraction for myopic astigmatism
por: Liu, Ting, et al.
Publicado: (2017)

Correlations among peripapillary vasculature, macular superficial capillaries, and eye structure in healthy and myopic eyes of Chinese young adults (STROBE)
por: Guo, Yuxia, et al.
Publicado: (2020)

Multiple evanescent white dot syndrome in highly myopic eye in which fundus autofluorescence was diagnostically useful: A case report
por: Harada, Sumine, et al.
Publicado: (2023)

Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin‐treated glaucoma patients
por: Aihara, Makoto, et al.
Publicado: (2017)

Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
por: Inatani, Masaru, et al.
Publicado: (2023)

Reversal of Myopic Correction for Patients Intolerant to LASIK
por: Gab-Alla, Amr A.
Publicado: (2021)

Comparison of anterior chamber angle changes following phakic intraocular lens with and without a central hole implantation for moderate to high myopic eyes
por: Zhou, Tian’an, et al.
Publicado: (2020)

Rescue of exotropia subsequent to pulled-in-two syndrome of the medial rectus muscle occurring during surgery for high myopic strabismus fixus: A case report
por: Nakao, Shinya, et al.
Publicado: (2022)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
por: Nakakura, Shunsuke, et al.
Publicado: (2012)

Pooled results of two randomized clinical trials comparing the efficacy and safety of travoprost 0.004%/timolol 0.5% in fixed combination versus concomitant travoprost 0.004% and timolol 0.5%
por: Gross, Ronald L, et al.
Publicado: (2007)

Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension
por: Baiza-Durán, Leopoldo Martín, et al.
Publicado: (2012)

Is the axial length a risk factor for post-LASIK myopic regression?
por: Gab-Alla, Amr A.
Publicado: (2020)

Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
por: Shimizu, Yoshie, et al.
Publicado: (2015)

Comparison of effectiveness between complete internal limiting membrane peeling and internal limiting membrane peeling with preservation of the central fovea in combination with 25G vitrectomy for the treatment of high myopic foveoschisis
por: Wang, Lifei, et al.
Publicado: (2019)

A Comfort Survey of Timolol Hemihydrate 0.5% Solution Once or Twice Daily vs Timolol Maleate in Sorbate
por: Stewart, William C, et al.
Publicado: (2013)

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
por: Rhee, Douglas J, et al.
Publicado: (2008)

Long-Term Comparison of Posterior Chamber Phakic Intraocular Lens With and Without a Central Hole (Hole ICL and Conventional ICL) Implantation for Moderate to High Myopia and Myopic Astigmatism: Consort-Compliant Article
por: Shimizu, Kimiya, et al.
Publicado: (2016)

Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%)
por: Gheith, Moataz E, et al.
Publicado: (2008)

Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial
por: Goldberg, Ivan, et al.
Publicado: (2014)

The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis
por: Gao, Yue, et al.
Publicado: (2022)

Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice
por: Lanzl, Ines, et al.
Publicado: (2011)

Abstract: Topical 0.5% Timolol for Chronic Refractory Wounds. an Observational Prospective Study
por: Vestita, Michelangelo, et al.
Publicado: (2017)

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma
por: Wu, Hai Wei, et al.
Publicado: (2017)

Atypical Regressive Corneal Endothelial Cysts in Long-Term Confocal Follow-Up: A Case Report
por: Smedowski, Adrian, et al.
Publicado: (2015)

Spontaneous regression of immunoglobulin G4-related dacryoadenitis and multiple organ involvement: A case report
por: Ito, Mayari, et al.
Publicado: (2023)

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure
por: Lee, Anne J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_7tgvd7i6975tkdtea121figgse